StonvexLoading…
StonvexStonvexStonvexCore line items from CNXN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.87B | $2.80B | $2.85B | $3.12B |
Operating Income | $99.28M | $97.06M | $103.15M | $120.55M |
Net Income | $83.72M | $87.09M | $83.27M | $89.22M |
EPS (Diluted) | $3.27 | $3.29 | $3.15 | $3.37 |
Total Assets | $1.35B | $1.30B | $1.19B | $1.10B |
Total Liabilities | $440.80M | $388.36M | $347.61M | $333.65M |
Cash & Equivalents | $193.22M | $178.32M | $144.95M | $122.93M |
Free Cash Flow OCF − CapEx | $58.05M | $166.29M | $188.36M | Not available |
Shares Outstanding | 25.22M | 26.30M | 26.36M | 26.35M |